Contact the ACC Registration and Housing Center

  • 864-208-2670
  • M-F, 9:00 a.m. - 5:00 p.m. ET
  • ACC@maritz.com
  • Questions? Learn more with our FAQs.


    Innovation Stage

    The Innovation Stage will offer 1 channel of streaming content from industry partners offering insights into cardiovascular innovations during 30-minute sessions.

    Quick Links: SaturdaySundayMonday

    SATURDAY, MAY 15

    9:45 a.m. – 10:15 a.m.

    4201. Session Title To Be Announced
    Innovation Stage 1
    Sponsored by Siemens Healthineers

    10:45 a.m. – 11:15 a.m.

    4202. Clinical Insights: Management of Patients With NVAF or Chronic CAD/PAD
    Innovation Stage 1
    Sponsored by Janssen Pharmaceuticals, Inc.

    This lecture will discuss the risk of stroke in patients with nonvalvular atrial fibrillation (NVAF), coronary artery disease (CAD), or peripheral artery disease (PAD), and will present options for reducing the risk of stroke and major cardiovascular events in patients with NVAF and CAD/PAD, respectively.

    Speaker:
    Matthew Charles Becker, MD, FACC, FSCAI, FSVM
    Director, Structural and Peripheral Intervention
    Director, Cardiac Catheterization Laboratories
    President, Panvascular Consulting Group, LLC
    Saint Vincent Heart and Vascular Institute
    Erie, Pennsylvania

    12:30 p.m. – 1:00 p.m.

    4203. Clinical Insights: Management of Patients With NVAF or Chronic CAD/PAD
    Innovation Stage 1
    Sponsored by Janssen Pharmaceuticals, Inc.

    This lecture will discuss the risk of stroke in patients with nonvalvular atrial fibrillation (NVAF), coronary artery disease (CAD), or peripheral artery disease (PAD), and will present options for reducing the risk of stroke and major cardiovascular events in patients with NVAF and CAD/PAD, respectively.

    Speaker:
    Dharmesh Patel, MD, MBBS (LONDON), FACC, FNLA, FACP, FASPC
    Cardiologist
    Stern Cardiovascular Foundation
    Memphis, Tennessee

    1:30 p.m. – 2:00 p.m.

    4204. Clinical Insights: Management of Patients With NVAF or Chronic CAD/PAD
    Innovation Stage 1
    Sponsored by Janssen Pharmaceuticals, Inc.

    This lecture will discuss the risk of stroke in patients with nonvalvular atrial fibrillation (NVAF), coronary artery disease (CAD), or peripheral artery disease (PAD), and will present options for reducing the risk of stroke and major cardiovascular events in patients with NVAF and CAD/PAD, respectively.

    Speaker:
    Sandeep Nathan, MD, MSC
    Associate Professor of Medicine
    University of Chicago Medicine
    Chicago, Illinois

    3:45 p.m. – 4:15 p.m.

    4205. Session Title To Be Announced
    Innovation Stage 1
    Sponsored by Siemens Healthineers

    SUNDAY, MAY 16

    9:45 a.m. – 10:15 a.m.

    4206. Inserting Implantable Cardiac Monitors (ICMs) in the Office: A Clinically Proven, Safe, and Efficient Option For Expanding Access to Patients
    Innovation Stage 1
    Sponsored by Medtronic

    In this session, you'll discover how safe, simple, and streamlined it is to perform the insertion of implantable cardiac monitors (ICMs) or otherwise known as implantable loop recorders (ILRs) out of the cath lab and in an office setting. We'll share an overview of the Medtronic LINQ Family of ICMs, highlight the clinical evidence that illustrates the safety and efficiency of in-office insertions, and give you a hands-on demonstration of a LINQ insertion workflow in-office.

    Speakers:
    Amy Anderson
    Senior Marketing Program Manager

    Beth Hoffman
    Medical Safety Program Manager, PA-C

    Grant Neitzell
    Principal Technical Field Engineer

    12:30 p.m. – 1:00 p.m.

    4207. Exploring New Synergies: Integrating a Cardiac CT Scanner and Interventional C-arm in our Cath Lab
    Innovation Stage 1
    Sponsored by Canon Medical Systems

    Attendees have the opportunity to gain exclusive insights into the World's First implementation of a hybrid angio-CT system in Interventional Cardiology from renowned experts in the field. See how our clinical partners are innovating new synergies with integration of a cardiac CT scanner and an interventional C-arm in the cathlab using Canon Medical's 4D CT system. Learn about the benefits of using advanced cardiac CT imaging in the cathlab and how intraprocedural CT guidance supports optimization of structural heart procedures, left atrial appendage occlusions and see the potential for a one-stop-shop approach for the diagnosis and treatment of chest pain.

    Speakers:
    Mahdi Veillet-Chowdhury, MD
    WellSpan York Hospital, York, PA

    James Harvey, MD
    WellSpan York Hospital, York, PA

    Brian Schuler, MD
    WellSpan York Hospital, York, PA

    Mahdi Veillet-Chowdhury, MD
    WellSpan York Hospital, York, PA

    1:30 p.m. – 2:00 p.m.

    4208. Session Title To Be Announced
    Innovation Stage 1
    Sponsored by Siemens Healthineers

    3:45 p.m. – 4:15 p.m.

    4209. Session Title To Be Announced
    Innovation Stage 1
    Sponsored by Medtronic

    MONDAY, MAY 17

    9:45 a.m. – 10:15 a.m.

    4210. How We Care For CAD Patients With Kidney Injury: Ultra-low Contrast PCI
    Innovation Stage 1
    Sponsored by Philips North America LLC

    How should we be thinking about care for our CAD patients with Chronic Kidney Disease? Renowned nephrologist Glenn Chertow shares insights into how we maximize patient outcomes as we treat CAD. Dr. Ziad Ali teaches interventionalists how to reduce or eliminate contrast in PCI for CKD patients, reducing the risk of complications.

    Speakers:
    Dr. Ziad Ali
    Director of Investigational Interventional Cardiology
    St. Francis Hospital, Roslyn, NY

    Dr. Glenn Chertow
    Chief of Nephrology and Professor of Medicine Stanford University School of Medicine
    Palo Alto, CA

    12:30 p.m. – 1:00 p.m.

    4211. Fusion Imaging For Transcatheter Edge-to-Edge Repair and Left Atrial Appendage Occlusion
    Innovation Stage 1
    Sponsored by Philips North America LLC

    A review of the current state-of-the-art practice, including case examples, for planning and guiding transcatheter edge-to-edge mitral valve repair and left atrial appendage occlusion interventions. What are the roles of echo and CT in planning TEER and LAAO interventions? How are fluoroscopy, echocardiography and fusion imaging (echo/fluoro, CT/fluoro) used in guiding TEER and LAAO interventions? What are the critical points in each procedure where fusion imaging can make a difference?

    Speakers:
    Tilak K.R. Pasala, MD, FACC, FSCAI
    Interim Director, Structural and Congenital Heart Center
    Program Director, Structural Heart Disease Fellowship
    Hackensack University Medical Center
    Hackensack, New Jersey

    Lucy M. Safi, DO, FACC, FASE
    Director of Interventional Echocardiography
    Hackensack University Medical Center
    Hackensack, New Jersey

    Information current as of March 31, 2021.

    Innovation Stage presentations are not part of ACC.21, as planned by its Program Committee, and do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

    ADVERTISEMENT
    ACC Logo
    ACC.21 on Social Media:
                       
    2021 American College of Cardiology Foundation. Visit ACC.org
    Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Cookie Policy Contact Us